REGULATION OF MIS TYPE II RECEPTOR AND TARGET GENES

MIS II 型受体和靶基因的调控

基本信息

  • 批准号:
    6376932
  • 负责人:
  • 金额:
    $ 13.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-04-01 至 2003-03-31
  • 项目状态:
    已结题

项目摘要

Mullerian Inhibiting Substance, a member of the TGF-beta superfamily of growth and differentiation factors, is produced by Sertoli cells during embryonal development and is required for normal reproductive development in male embryos. The signal activity of MIS is the regression of the Mullerian duct, the precursor of the uterus, fallopian tubes and upper vagina. MIS is also produced both in the adult testis by Sertoli cells and in the ovary by granulosa cells, where its exact role remains to be fully explored. Based on in vitro and in vivo evidence, it is our hypothesis that signal transduction by MIS, via its heteromeric serine/threonine kinase receptor, is required to maintain reproductive competence of the gonad and to prevent hyperplastic growth. The goal of this proposal is to (I) understand the developmental, cell- specific and sexually dimorphic molecular mechanisms regulating the expression of the MIS type II receptor (MISrII) in Leydig cells, Sertoli cells, and granulosa cells during different stages of the development and also in the mesenchymal cells surrounding the Mullerian duct during embryonal development and (II) to uncover target genes whose expression is regulated by MIS signal transduction. Since we have cloned the MISrII gene with its TATA-less promoter and have identified cell lines expressing endogenous MISrII, we now have the tools to study expression of MISrII and its downstream target genes. To analyze the MISrII promoter, we will express chimeric promoter/ reporter constructs in MIS type II receptor expressing cells, then perform DNase I footprinting and gel shift analysis, with nuclear extracts prepared from those cells, to determine the cis-acting DNA elements necessary and sufficient for transcription and to examine the role of TFII-I in assembly of the pre-initiation complex. Sequences identified will be used for oligoaffinity purification of trans-acting factors which bind to those sequences. We will also immortalize the Mullerian duct mesenchymal cells which undergo apoptosis and regression in response to MIS to provide cell lines in which to identify downstream, transcriptionally regulated target genes of MIS participating in this important process. We will approach this by studying candidate genes that we might expect to be regulated. We will also perform subtractive hybridization with both R2C cells which respond to MIS, express the receptor, and from which we recently constructed a cDNA library. Information uncovered by these studies will contribute to our understanding of how MIS initiates apoptosis and causes G1 arrest and that these molecular mechanisms can be harnessed for the control of tumors known to respond to MIS, such as human ovarian cancer.
苗勒管抑制物质,TGF-β超家族的成员 生长和分化因子,由支持细胞在生长过程中产生 胚胎发育,是正常生殖所必需的 男性胚胎的发育。 MIS 的信号活动是 苗勒氏管(子宫、输卵管的前身)退化 管和上阴道。 MIS 也在成人睾丸中产生 由支持细胞和卵巢中的颗粒细胞组成,其确切的位置 的作用还有待充分探讨。 基于体外和体内 证据,我们的假设是 MIS 的信号转导通过其 异聚丝氨酸/苏氨酸激酶受体,需要维持 性腺的生殖能力并防止增生性生长。 该提案的目标是(I)了解发育、细胞- 调节特定和性别二态性的分子机制 MIS II 型受体 (MISrII) 在间质细胞、支持细胞中的表达 不同发育阶段的细胞和颗粒细胞 以及苗勒氏管周围的间充质细胞 胚胎发育和(II)发现其表达的靶基因 受 MIS 信号转导调节。 由于我们已经克隆了 MISrII 基因及其无 TATA 启动子,并且 已经鉴定出表达内源性 MISrII 的细胞系,我们现在拥有 研究 MISrII 及其下游靶基因表达的工具。 为了分析 MISrII 启动子,我们将表达嵌合启动子/ 在 MIS II 型受体表达细胞中构建报告基因,然后 使用核进行 DNase I 足迹分析和凝胶位移分析 从这些细胞中制备提取物,以确定顺式作用 DNA 转录和检查所必需和充分的元素 TFII-I 在预起始复合物组装中的作用。 序列 鉴定将用于反式作用的寡亲和纯化 与这些序列结合的因子。 我们也将永垂不朽 苗勒氏管间充质细胞发生凋亡和退化 响应 MIS,提供可识别的细胞系 MIS 的下游转录调控靶基因 参与这一重要进程。 我们将通过以下方式解决这个问题 研究我们可能期望受到调控的候选基因。 我们将 还与响应的 R2C 细胞进行消减杂交 到 MIS,表达受体,我们最近从中构建了一个 cDNA文库。 这些研究发现的信息将有助于 帮助我们了解 MIS 如何启动细胞凋亡并导致 G1 期停滞 并且可以利用这些分子机制来控制 已知对 MIS 有反应的肿瘤,例如人类卵巢癌。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSE M. TEIXEIRA其他文献

JOSE M. TEIXEIRA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSE M. TEIXEIRA', 18)}}的其他基金

Stem cell epigenetics in uterine fibroids
子宫肌瘤的干细胞表观遗传学
  • 批准号:
    10200875
  • 财政年份:
    2020
  • 资助金额:
    $ 13.35万
  • 项目类别:
Patient-specific targeting of uterine fibroids
针对子宫肌瘤的患者特异性靶向治疗
  • 批准号:
    10004135
  • 财政年份:
    2019
  • 资助金额:
    $ 13.35万
  • 项目类别:
Patient-specific targeting of uterine fibroids
针对子宫肌瘤的患者特异性靶向治疗
  • 批准号:
    10401333
  • 财政年份:
    2019
  • 资助金额:
    $ 13.35万
  • 项目类别:
Patient-specific targeting of uterine fibroids
针对子宫肌瘤的患者特异性靶向治疗
  • 批准号:
    10621179
  • 财政年份:
    2019
  • 资助金额:
    $ 13.35万
  • 项目类别:
Uterine Leiomyoma Development in Mouse Models
小鼠模型中子宫肌瘤的发育
  • 批准号:
    8439082
  • 财政年份:
    2013
  • 资助金额:
    $ 13.35万
  • 项目类别:
Endocrine disruption of myometrial stem cell activities
子宫肌干细胞活性的内分泌干扰
  • 批准号:
    8896094
  • 财政年份:
    2013
  • 资助金额:
    $ 13.35万
  • 项目类别:
Uterine Leiomyoma Development in Mouse Models
小鼠模型中子宫肌瘤的发育
  • 批准号:
    9277297
  • 财政年份:
    2013
  • 资助金额:
    $ 13.35万
  • 项目类别:
Endocrine disruption of myometrial stem cell activities
子宫肌干细胞活性的内分泌干扰
  • 批准号:
    8679137
  • 财政年份:
    2013
  • 资助金额:
    $ 13.35万
  • 项目类别:
Uterine Leiomyoma Development in Mouse Models
小鼠模型中子宫肌瘤的发育
  • 批准号:
    8738697
  • 财政年份:
    2013
  • 资助金额:
    $ 13.35万
  • 项目类别:
Endocrine disruption of myometrial stem cell activities
子宫肌干细胞活性的内分泌干扰
  • 批准号:
    8711586
  • 财政年份:
    2013
  • 资助金额:
    $ 13.35万
  • 项目类别:

相似海外基金

Establishment of engraftment of the Leydig cells derived from human iPS cells and acquisition of preclinical POC
建立源自人 iPS 细胞的 Leydig 细胞移植并获得临床前 POC
  • 批准号:
    23H03037
  • 财政年份:
    2023
  • 资助金额:
    $ 13.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Experiments on the generation of human iPS cell-derived testosterone-producing Leydig cells and their clinical application
人iPS细胞来源的睾酮产生Leydig细胞的产生实验及其临床应用
  • 批准号:
    20K09578
  • 财政年份:
    2020
  • 资助金额:
    $ 13.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular basis of fetal differentiation memory retention in testicular Leydig cells
阐明睾丸间质细胞胎儿分化记忆保留的分子基础
  • 批准号:
    19K07378
  • 财政年份:
    2019
  • 资助金额:
    $ 13.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mediators for dynamic regulation of Star transcription in Leydig cells
Leydig 细胞中 Star 转录动态调节的介质
  • 批准号:
    10152639
  • 财政年份:
    2017
  • 资助金额:
    $ 13.35万
  • 项目类别:
Mediators for dynamic regulation of Star transcription in Leydig cells
Leydig 细胞中 Star 转录动态调节的介质
  • 批准号:
    9402971
  • 财政年份:
    2017
  • 资助金额:
    $ 13.35万
  • 项目类别:
Mediators for dynamic regulation of Star transcription in Leydig cells
Leydig 细胞中 Star 转录动态调节的介质
  • 批准号:
    9924272
  • 财政年份:
    2017
  • 资助金额:
    $ 13.35万
  • 项目类别:
Mechanism of differentiation of fetal Leydig cells by active and suppressive types of nuclear receptors
活性和抑制型核受体分化胎儿间质细胞的机制
  • 批准号:
    16H05142
  • 财政年份:
    2016
  • 资助金额:
    $ 13.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Differentiation of Leydig cells
间质细胞的分化
  • 批准号:
    16K15688
  • 财政年份:
    2016
  • 资助金额:
    $ 13.35万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
MEF2 and COUP-TFII cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells
MEF2 和 COUP-TFII 协同调节小鼠 MA-10 Leydig 细胞中的 Akr1c14 基因表达
  • 批准号:
    324323
  • 财政年份:
    2015
  • 资助金额:
    $ 13.35万
  • 项目类别:
Activation of AMPK actively represses steroid hormone synthesis in MA-10 Leydig cells
AMPK 的激活主动抑制 MA-10 Leydig 细胞中类固醇激素的合成
  • 批准号:
    263350
  • 财政年份:
    2012
  • 资助金额:
    $ 13.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了